3rd Quarter - Report

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
—
Expenses
$1,980,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

10 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

- Issues related to the NAFTA renegotiation issues. - Issues related to miscellaneous trade bills. - Issues related to new tariff proclamations and retaliation.

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —

Contacted: HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); White House Office; SENATE

Taxation/Internal Revenue Code TAX

- S.85/H.R.394, "Restoring Access to Medication Act of 2017", regarding all provisions. - Issues related to Mobile Workforce legislation. - Issues related to OECD tax reporting. - Issues related to Puerto Rico tax treatment. - Regulations implementing PL 115-97, "Tax Cut & Jobs Act", regarding all provisions.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
ANNE BRUCE —
DARREL C JODREY —
DAVID KAVANAUGH —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Veterans Affairs, Dept of (VA); SENATE

Bills named: H.R. 394 (115th), S. 85 (115th)

Copyright/Patent/Trademark CPT

- S.1390/H.R.5340, "STRONGER Patents Act of 2018", regarding all provisions. - Patent Trade Office reforms

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —

Contacted: Veterans Affairs, Dept of (VA); SENATE; HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 5340 (115th), S. 1390 (115th)

Health Issues HCR

- S. 469/H.R. 1245, "Affordable and Safe Prescription Drug Importation Act", regarding all provisions. - S. 771/H.R. 1776, "Improving Access To Affordable Prescription Drugs Act", regarding all provisions. - H.R. 575, "Cosmetic Modernization Amendments of 2017", regarding all provisions. - H.R. 1271, "DXM Abuse Prevention Act of 2017", regarding all provisions. - S. 404/H.R. 1736, "To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.", regarding all provisions. - Issues regarding drug pricing. - Issues related to diagnostic reform. - S 260/SJ Res 17/HR 849, Protecting Seniors' Access to Medicare Act of 2017, regarding all provisions - S 251/SJ Res 16, Protecting Medicare from Executive Action Act of 2017, regarding all provisions - S 204/HR 878, Right to Try Act of 2017, regarding all provisions - HR 2026, Pharmaceutical Information Exchange Act, regarding all provisions - HR 1703, Medical Product Communications Act of 2017, regarding all provisions - Issues related to VA procurement of medical devices - HR 2474, Medical Product Review Harmonization Act, regarding all provisions - HR 2144, Risk Based Classification of Accessories Act - Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects - S.1113, "Personal Care Products Safety Act", regarding all provisions - HR 2790, "Humane Cosmetics Act", regarding all provisions - HR 3271, "Protecting Access to Diabetes Supplies Act", regarding all provisions - Issues regarding medical device repeal - Issues regarding NIH Funding - HR 2164, "Medical Device Safety Act", regarding all provisions - Issues related to 340B - Issues related to HIV vaccines - S. 2852, "Pandemic & All Hazards Preparedness and Advancing Innovations Act of 2018", regarding all provisions. - Issues related to reauthorization of the Pandemic All-Hazards Preparedness Act programs. (House version) - HR 5492, "MOTHER Act of 2018", regarding all provisions. - Issues related to access to essential surgery - Issues related to contact lens safety - HR 6, "SUPPORT for Patients and Communities Act", regarding all provisions. - S. 2315, "Over-the-Counter Drug Safety, Innovation, and Reform Act", regarding all provisions. - HR 5333 "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018", regarding all provisions. - Issues related to antimicrobial resistance - Issues related to regulations on medication product packaging - H.R. 6294, " Re-Valuing Anti-Microbial Products Act of 2018", regarding all provisions

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA)

Bills named: H.R. 3271 (115th), S. 469 (115th), S.J.Res. 17 (115th), H.R. 2164 (115th), H.R. 1736 (115th), H.R. 849 (115th), H.R. 1271 (115th), H.R. 1245 (115th), H.R. 2026 (115th), H.R. 2790 (115th), H.R. 6294 (115th), S. 2315 (115th), H.R. 575 (115th), H.R. 5492 (115th), S. 2852 (115th), S.J.Res. 16 (115th), H.R. 1703 (115th), H.R. 878 (115th), H.R. 1776 (115th), S. 404 (115th), H.R. 2144 (115th), H.R. 2474 (115th), H.R. 6 (115th), S. 771 (115th), S. 1113 (115th), H.R. 5333 (115th)

Veterans VET

- Issues regarding Healthy Heroes, partnership with the VA on Suicide Prevention, integrated marketing, clinical trials and personalized medicine. - VA medical device procurement issues.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
ANNE BRUCE —
LAURYL DODSON JACKSON —
MEGHAN DRENAN STONE —

Contacted: Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; SENATE; White House Office

Medicare/Medicaid MMM

- Issues related to competitive bidding. - Issues related to patient access. - Issues related to expanded access. -HR 4683 - "To amend title XVIII of the Social Security Act to revise the NTAP period under the Medicare inpatient prospective payment system and the pass-through period under the Medicare outpatient prospective payment system", regarding all provisions. - Issues related to Medicare pass-through payments for biologics and biosimilar products. -Issues related to Medicare Part D

LobbyistCovered position, as disclosed
MICHAEL BARNARD —
CARLA CARTWRIGHT —
MEGHAN DRENAN STONE —

Contacted: HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); SENATE; White House Office

Bills named: H.R. 4683 (115th)

Budget/Appropriations BUD

S.Con.Res. 3, "A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.", regarding all provisions. HR 1892, "BiPartisan Budget Act", regarding all provisions. HR 1625, "Consolidated Appropriations Act", regarding all provisions.

Contacted: White House Office; SENATE; Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1625 (115th), H.R. 1892 (115th), S.Con.Res. 3 (115th)

Immigration IMM

H.R. 6136, Border Security and Immigration Reform Act of 2018, regarding provisions related to the Deferred Action for Childhood Arrivals (DACA) program H.R. 4760, Securing America's Future Act of 2018, regarding provisions related to the Deferred Action for Childhood Arrivals (DACA) program

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); SENATE

Bills named: H.R. 4760 (115th), H.R. 6136 (115th)

Labor Issues/Antitrust/Workplace LBR

- Issues related to shareholder reform. - Issues related to proxy advisory firm reform. - PL 115-97, "Tax Cuts & Jobs Act", regarding provisions related to SEC notification.

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —

Contacted: Veterans Affairs, Dept of (VA); SENATE; HOUSE OF REPRESENTATIVES; White House Office

Torts TOR

- Issues related to civil justice reform.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
CARLA CARTWRIGHT —

Contacted: HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); SENATE; White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.